Article
GRHL2 is a Candidate Prognostic and Immunotherapy Biomarker in Breast Cancer
2021-10-25
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>:Breast cancer (BC) is the most frequent malignancy in women worldwide and the leading cause of female cancer‐associated death in the world. Thus, we need to identify new biomarkers to predict the prognosis of BC. In mammals, the Grainyhead-like (GRHL) family of transcription factors has three members, called Grainyhead-like 1 (GRHL1), Grainyhead-like 2 (GRHL2) an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c08ce021-a004-5d72-8b2f-806fdf89841f
- DOI
- 10.21203/rs.3.rs-999774/v1
